| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |